ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2016 American Transplant Congress

    Matrix Metalloproteinase-9 in Human Orthotopic Liver Transplant Biopsies.

    S. Duarte, N. Datta, J. Baber, R. Busuttil, A. Zarrinpar, A. Coito.

    The Dumont-UCLA Transplant Center, Los Angeles.

    Liver ischemia reperfusion injury (IRI) is an inflammatory event that contributes to graft dysfunction in orthotopic liver transplantation (OLT). Matrix Metalloproteinases (MMPs) are responsible for…
  • 2016 American Transplant Congress

    Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

    A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.

    Baylor University Medical Center, Dallas, TX.

    IntroductionAutotransfusion (AT) is rarely used in liver transplantation of hepatocellular carcinoma (HCC) patients due to the fear of disease transmission. Leukocyte depleting filters (LDF) can…
  • 2016 American Transplant Congress

    Living Donor Liver Transplantation for Sick Patients with MELD Score ≥ 35.

    R.-S. Soong,1 Y.-C. Wang,1 C.-H. Cheng,1 T.-H. Wu,1 C.-F. Lee,1 T.-J. Wu,1 H.-S. Chou,1 K.-M. Chan,1 C.-S. Lee,2 W.-C. Lee.1

    1Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Taoyuan, Taiwan; 2Hepatology, Chang-Gung Memorial Hospital, Taoyuan, Taiwan.

    Background: The liver transplant candidates with MELD score ≥ 35 were very sick and with high mortality without liver transplantation. All these patients are in…
  • 2016 American Transplant Congress

    Renal Function Decline Is Higher in the First Year After Liver Transplantation: Final Results from the Italian Observational Study SURF.

    A. Giacomoni,1 M. Cescon,2 G. Magini,3 F. Picciotto,4 U. Cillo,5 M. Senzolo,5 G. Vennarecci,6 P. De Simone.7

    1AO Niguarda, Milano, Italy; 2AO S.Orsola-Malpighi, Bologna, Italy; 3AO Papa Giovanni XXIII, Bergamo, Italy; 4AO Cardarelli, Napoli, Italy; 5AOU di Padova, Padova, Italy; 6O S.Camillo, Roma, Italy; 7AOU Cisanello, Pisa, Italy.

    SURF registry was designed to investigate the evolution of renal function in Italian adult liver transplant (LT) recipients by: exploring the prevalence of chronic kidney…
  • 2016 American Transplant Congress

    Defining Frailty in Liver Transplant Recipients.

    L. Louwers,1 K. Eid,1 J. Plescia,1 N. Presser,1 J. Muntean,1 M. Kattan,2 K. Chagrin,2 C. Miller,1 D. Kelly.1

    1Surgery, Cleveland Clinic, Cleveland, OH; 2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH.

    PURPOSETo define frailty in the liver transplant (OLT) population to optimize care and assist in predicting post OLT outcomes.METHODSAll adult primary OLT patients from 01/2010…
  • 2016 American Transplant Congress

    Histone Deacetylase-2 Gene Deletion in Mice Mitigates Liver Ischemia/Reperfusion Injury.

    D. Murken,1 D. Aufhauser Jr,1 Z. Wang,2 G. Ge,2 W. Hancock,2,3 M. Levine.1,4

    1Department of Surgery, University of Pennsylvania, Philadelphia, PA; 2Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA; 3Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA; 4Department of Surgery, Children's Hospital of Philadelphia, Philadelphia, PA.

    Introduction: Ischemia/reperfusion injury (IRI) causes significant morbidity in liver transplantation and other surgical scenarios. A better understanding of the molecular mechanisms of IRI is required…
  • 2016 American Transplant Congress

    Review of Aborted Hepatectomy of Liver Transplantation in a Single Center Study.

    J. Lee, G. Choi, W. Cho, J.-W. Joh, S.-K. Lee, S.-J. Kim, C. Kwon, J. Park, J. Kim.

    General Surgery, Samsung Medical Center, Seoul, Korea.

    Liver transplantation (LT) has become a popular option for the treatment of endstage hepatic failure. More attention has been given to donor safety, but still…
  • 2016 American Transplant Congress

    Renal Outcomes of Pediatric Kidney Transplant Recipients Following a Previous Solid Organ Transplantation.

    G. Hamdani,1 B. Zhang,2 J. Goebel,3 E. Nehus.1

    1Division of Nephrology & Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 2Center for Epidemiology & Biostatistics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; 3Nephrology, Children's Hospital Colorado, Aurora, CO.

    Purpose: We aimed to study the renal outcomes of pediatric kidney transplant recipients following a previous non-renal solid organ transplantation (SOT).Methods: A retrospective analysis of…
  • 2016 American Transplant Congress

    Conversion to Once-Daily Tacrolimus in Stable Pediatric Liver Transplantation Recipients.

    N. Lee, S. Lee, C.-W. Cho, J. Lee, J. Lee, J. Kim, G.-S. Choi, C. Kwon, J.-W. Joh, S.-K. Lee.

    Department of Surgery Organ Transplant Center, Samsung Medical Center, Seoul, Republic of Korea.

    Purpose: Pediatric patients are known to have lower compliance than adult patients. Once-daily formulation of tacrolimus may increase compliance in pediatric liver transplant recipients. The…
  • 2016 American Transplant Congress

    Virological Response at 4 Weeks With a Sofosbuvir-Based Antiviral Regimen in Liver Transplant Recipients with Recurrent Hepatitis C.

    T. Pastrana-Camacho,1 M. Bradley,1 H. Winters,1 S. Black,2 K. Porter,3 K. Mumtaz.4

    1Pharmacy, The Ohio State University-Wexner Medical Center, Columbus, OH; 2Department of Surgery, The Ohio State University-Wexner Medical Center, Columbus, OH; 3Center for Biostatistics, The Ohio State University-Wexner Medical Center, Columbus, OH; 4Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, The Ohio State University-Wexner Medical Center, Columbus, OH.

    Background: The literature is growing in the area of safety, efficacy and tolerability of sofosbuvir (SOF)- based antivirals therapy (AVT) in recurrent hepatitis C virus…
  • « Previous Page
  • 1
  • …
  • 142
  • 143
  • 144
  • 145
  • 146
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences